Evoke Wealth’s Chemours CC Stock Holding History

Evoke Wealth’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-95	Closed	-$841	–	1081
2020 Q1	$841	Buy	95 +3	+3%	+$43	﹤0.01%	952
2019 Q4	$1.67K	Buy	+92	New	+$1.53K	﹤0.01%	1101

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Evoke Wealth's CC Position: Q2 2020 in Review

Evoke Wealth sold out of Chemours (CC) in Q2 2020, closing a stake of 95 shares — an estimated $841 sold.

Evoke Wealth first reported a position in CC in Q4 2019 and held it in 2 quarters. The position peaked at $1.67K in Q4 2019. 396 funds tracked by Wall St. Rank hold CC as of Q2 2020.

Evoke Wealth reported no remaining Chemours position as of Q2 2020 after selling out during the quarter.
Evoke Wealth sold 95 Chemours shares in Q2 2020, an estimated $841.
Evoke Wealth first reported a position in Chemours in Q4 2019 and held it in 2 quarters.
Evoke Wealth's Chemours position peaked at $1.67K in Q4 2019.
396 funds tracked by Wall St. Rank held Chemours as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.